United States

Aura Biosciences is a biotech company focused on developing therapies for cancer treatment. They use a virus-like drug conjugates (VDC) technology platform to target tumors in ocular and urologic oncology. Their main candidate, AU-011, is being developed for the treatment of primary choroidal melanoma and other ocular oncology indications. The company was founded in 2009 and is based in Cambridge, Massachusetts.

Google

Gerente de Producto

Científico de Datos

Aura Biosciences

Aura Biosciences Vacantes Abiertas

¿Estás listo para hacer crecer tu carrera? Revisa estas posiciones abiertas en Aura Biosciences.